Home › Mga Sakit sa Baga › Tennessee › Nashville

Pag-aaral pangklinika para sa Mga Sakit sa Baga sa Nashville, TN

Isang pag-aaral para sa Mga Sakit sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Nagre-recruitPhase 2

Premier Research Center, LLC, Hendersonville · 13 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06977581

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Nagre-recruitPhase 3

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06765109

American Lung Association (ALA) Lung Health Cohort

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Vanderbilt University Medical Center, Nashville

Edad 25 hanggang 35 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

Sarah Cannon Research Institue, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Tennessee Oncology, Nashville
USO - US Oncology Research Network, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Nagre-recruitPhase 2

Vanderbilt University Medical Center, Nashville

Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Nagre-recruitPhase 3

Clinical Trials Center of Middle Tennesee LLC, Franklin · 17 mi ang layo

Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284602

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05967689

Cooperative Assessment of Late Effects for SCD Curative Therapies

Nagre-recruitObservasyonal na pag-aaral

Vanderbilt University Medical Center, Nashville

Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05153967

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Nagre-recruitPhase 2

Tristar Bone Marrow Transplant, Nashville
Vanderbilt-Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561

Pag-aaral para sa Mga Sakit sa Baga sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.